This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dawson, K.
Right arrow Articles by Wilkinson, C. R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dawson, K.
Right arrow Articles by Wilkinson, C. R. M.

 Previous Article  |  Next Article 

Eukaryotic Cell, June 2008, p. 926-937, Vol. 7, No. 6
1535-9778/08/$08.00+0     doi:10.1128/EC.00037-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Loss of Regulators of Vacuolar ATPase Function and Ceramide Synthesis Results in Multidrug Sensitivity in Schizosaccharomyces pombe{triangledown}

Keren Dawson, W. Mark Toone,{dagger} Nic Jones,* and Caroline R. M. Wilkinson*

Paterson Institute for Cancer Research, University of Manchester, Wilmslow Road, Manchester M20 4BX, United Kingdom

Received 1 February 2008/ Accepted 11 April 2008

We undertook a screen to isolate determinants of drug resistance in fission yeast and identified two genes that, when mutated, result in sensitivity to a range of structurally unrelated compounds, some of them commonly used in the clinic. One gene, rav1, encodes the homologue of a budding yeast protein which regulates the assembly of the vacuolar ATPase. The second gene, lac1, encodes a homologue of genes that are required for ceramide synthesis. Both mutants are sensitive to the chemotherapeutic agent doxorubicin, and using the naturally fluorescent properties of this compound, we found that both rav1 and lac1 mutations result in an increased accumulation of the drug in cells. The multidrug-sensitive phenotype of rav1 mutants can be rescued by up-regulation of the lag1 gene which encodes a homologue of lac1, whereas overexpression of either lac1 or lag1 confers multidrug resistance on wild-type cells. These data suggest that changing the amount of ceramide synthase activity in cells can influence innate drug resistance. The function of Rav1 appears to be conserved, as we show that SpRav1 is part of a RAVE-like complex in fission yeast and that loss of rav1 results in defects in vacuolar (H+)-ATPase activity. Thus, we conclude that loss of normal V-ATPase function results in an increased sensitivity of Schizosaccharomyces pombe cells to drugs. The rav1 and lac1 genes are conserved in both higher eukaryotes and various pathogenic fungi. Thus, our data could provide the basis for strategies to sensitize tumor cells or drug-resistant pathogenic fungi to drugs.


* Corresponding author. Mailing address for N. Jones: Paterson Institute for Cancer Research, University of Manchester, Wilmslow Road, Manchester M20 4BX, United Kingdom. Phone: 44 161 446 3129. Fax: 44 161 446 3109. E-mail: njones{at}picr.man.ac.uk. Mailing address for C. R. M. Wilkinson: Paterson Institute for Cancer Research, University of Manchester, Wilmslow Road, Manchester M20 4BX, United Kingdom. Phone: 44 161 446 3129. Fax: 44 161 446 3109. E-mail: cwilkinson{at}picr.man.ac.uk

{triangledown} Published ahead of print on 25 April 2008.

{dagger} Present address: Samuel Lunenfeld Research Institute, Toronto, Ontario M5G1X5, Canada.


Eukaryotic Cell, June 2008, p. 926-937, Vol. 7, No. 6
1535-9778/08/$08.00+0     doi:10.1128/EC.00037-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.